Screening Protocol for Children and Adolescents With Bipolar and Bipolar Spectrum Disorder
NCT00592267 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-01-18
Summary
The objective of this protocol is to establish a comprehensive screening process for the evaluation of eligibility for entry in a clinical trial program for children and adolescents with bipolar disorder.
Conditions
- Pediatric Bipolar Disorder
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Joseph Biederman, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 4 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
Juvenile Bipolar Disorder Outpatient Program
NCT01000402 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents
NCT00332098 ·Status: COMPLETED ·Phase: PHASE3
-
Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
NCT00181844 ·Status: COMPLETED ·Phase: PHASE4
-
Early Intervention for Youth at Risk for Bipolar Disorder
NCT01483391 ·Status: COMPLETED ·Phase: NA
-
Bipolarity - Depression in Children and Adolescent Suicide Attempters: Better Diagnosis to Prevent Recurrence
NCT03116503 ·Status: COMPLETED ·Phase: NA
-
Bipolar Disorder Study for Men and Women
NCT00056277 ·Status: COMPLETED ·Phase: PHASE3
-
Greater Houston Area Pediatric Bipolar Registry
NCT06665984 ·Status: RECRUITING
-
Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
NCT02357290 ·Status: COMPLETED ·Phase: PHASE4
-
Children's Bipolar Network Treatment Trial I
NCT05427123 ·Status: RECRUITING
-
Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
NCT00181883 ·Status: COMPLETED ·Phase: PHASE4
-
Spectroscopy in Children and Adolescents With Bipolar Disorder
NCT00181831 ·Status: COMPLETED
-
Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar Disorder
NCT05209217 ·Status: UNKNOWN
-
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
NCT06229210 ·Status: RECRUITING ·Phase: PHASE3
-
PET and MRI Brain Imaging of Bipolar Disorder
NCT01880957 ·Status: COMPLETED ·Phase: NA
-
Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder
NCT01126827 ·Status: COMPLETED ·Phase: NA
-
A Brief Family-centered Care Program for Bipolar Disorder
NCT02893007 ·Status: COMPLETED ·Phase: NA
-
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761 ·Status: COMPLETED ·Phase: PHASE3
-
Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
NCT00592852 ·Status: TERMINATED ·Phase: PHASE4
-
Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder
NCT00943085 ·Status: COMPLETED ·Phase: NA
-
Treatment of Depression in Youth With Bipolar Disorders
NCT00005015 ·Status: TERMINATED ·Phase: PHASE3
-
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
NCT01282281 ·Status: COMPLETED
-
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
NCT00176228 ·Status: COMPLETED ·Phase: PHASE2
-
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
NCT00221429 ·Status: COMPLETED ·Phase: PHASE3
-
Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker Panel
NCT01957501 ·Status: TERMINATED
-
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
NCT02596698 ·Status: COMPLETED